Holen Sie sich die Stockscreener-App
2.64
9.09%
0.22
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ - TradingView
Form DEF 14A Matinas BioPharma Holdings Inc For: 29 September By Investing.com - Investing.com Canada
Matinas Biopharma Holdings, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (MTNB) - Traders Union
Matinas BioPharma Implements One-for-Fifteen Reverse Stock Split - TipRanks
Stock splits calendar for: - Yahoo Finance Singapore
Matinas BioPharma (MTNB) Climbs 8.4% as Sub-$1 Biotech Pushes Toward $0.18 ResistanceInitial Balance - siam.in
Live Matinas Biopharma Holdings, Inc. (MTNB) Technical Analysis - Traders Union
Matinas Biopharma Holdings, Inc. (MTNB) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Matinas BioPharma announces one-for-fifteen reverse stock split approval - Investing.com
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com Australia
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com Canada
Matinas BioPharma Announces One-for-Fifteen Reverse Stock Split - TipRanks
Matinas BioPharma to implement 1-for-15 reverse stock split effective Sept. 28, 2026 - TradingView
A first commercial hydrogen deal covers up to 1,000 kilograms a day from GH Power’s facility. - Stock Titan
Price to sales forward of Matinas Biopharma Holdings, Inc. – BOATS:MTNB - TradingView
Matinas BioPharma Share PriceMTNB, RNS News, Articles, Quotes, & Charts (OTCMKTS:MTNB) - Proactive financial news
Matinas Biopharma (MTNB) Holds Steady at $0.18 as Key Support HoldsRVOL Breakout - dars.gov.et
Matinas BioPharma Faces NYSE American Compliance Challenges - TipRanks
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - The Manila Times
Matinas BioPharma Receives New NYSE American Delisting Risk on Equity Shortfall - minichart.com.sg
Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Received Notice of Noncompliance - tradingview.com
symbol__ Stock Quote Price and Forecast - CNN
MTNB Q4 2024 Earnings: Narrower-than-Expected Loss Still Overshadowed by Zero RevenueOne-Time Loss Impact - dars.gov.et
Matinas (MTNB) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 1.16% Down at the ClosePerformance Review - vinanet.vn
Matinas (MTNB) Session: Finishes 1.16% Down at $0.20 on the Day; Levels: the Near-Term Reference Band Stretches From $0.19 to $0.21 in the Current UpdateWave Equality - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingShare Repurchase Impact - vinanet.vn
Matinas (MTNB) Trading: Finishes 8.93% Higher at $0.20 in the Latest Session; Key Range: the Supplied Trading Band Runs From $0.19 to $0.21 under the Current SnapshotLong Term Entry Picks - dars.gov.et
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Top Premarket Decliners - marketscreener.com
Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Warning Signal - vinanet.vn
Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportInitial Balance - dars.gov.et
US Micro Cap StocksInvest from India - INDmoney
Matinas BioPharma Holdings Inc (MTNB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Matinas BioPharma (MTNB) to merge into new GH Power International parent - stocktitan.net
MTNB Q4 2024 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineNew Analyst Coverage - dars.gov.et
GH Power and TKMS Continue to Explore Clean Energy Collaboration in Support of Canada’s Future Patrol Submarine Project - Business Wire
Matinas BioPharma (MTNB) and GH Power set 91/9 split in NYSE American deal - Stock Titan
MTNB|Matinas BioPharma Holdings Inc|Price:0.335|Chg%:+0.093 - TradingKey
Matinas BioPharma Holdings Inc - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Institutional Confidence - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):